xRead - Facial Reconstruction Following Mohs Micrographic Surgery
Archives of Dermatological Research (2023) 315:1853–1861
1859
References 1. Harvey DT, Taylor RS, Itani KM, Loewinger RJ (2013) Mohs micrographic surgery of the eyelid: an overview of anatomy, pathophysiology, and reconstruction options. Dermatol Surg 39(5):673–697. https://doi.org/10.1111/dsu.12084 2. Esteves TC, Catorze MG, Themido R, Labareda JM, Bordalo O, Picoto A (2010) Malignant eyelid tumours treated with Mohs’ micrographic surgery: Review of 22 years. Skin Cancer 25:11–19 3. Seo YJ, Hwang C, Choi S, Oh SH (2009) Midface reconstruction with various flaps based on the angular artery. J Oral Maxillofac Surg 67(6):1226–1233. https://doi.org/10.1016/j.joms.2008.06. 097 4. Ibrahim AMS, Rabie AN, Borud L, Tobias AM, Lee BT, Lin SJ (2014) Common patterns of reconstruction for Mohs defects in the head and neck. J Craniofac Surg 25(1):87–92. https://d oi.o rg/ 10.1097/SCS.0b013e3182a2e9eb 5. Çölo ǧ lu H, Koçer U, Oruç M, Şahin B, Özdemir R (2007) Axial bilobed superficial temporal artery island flap (tulip flap): recon struction of combined defects of the lateral canthus including the lower and upper eyelids. Plast Reconstr Surg 119(7):2080–2087. https://doi.org/10.1097/01.prs.0000260602.32664.ba 6. Iuliano A, Tranfa F, Clemente L, Fossataro F, Strianese D (2019) A case series of Merkel cell carcinoma of the eyelid: a rare entity often misdiagnosed. Orbit 38(5):395–400. https://d oi.o rg/1 0.1 080/ 01676830.2018.1537291 7. Totir M, Alexandrescu C, Pirvulescu R, Gradinaru S, Costache M (2014) Clinical, histopathological and therapeutical analysis of inferior eyelid basal cell carcinomas. J Med Life 7(4):18–22 8. Chahal HS, Allen RC (2016) Combination lateral rotational and glabellar flaps for medial canthal defects. JAMA Facial Plast Surg 18(6):491–492. https://doi.org/10.1001/jamafacial.2016.1026 9. Choi JS, Bae YC, Nam SB, Bae SH, Kim GW (2018) Evaluation of the donor site after the median forehead flap. Arch Plast Surg 45(3):259–265. https://doi.org/10.5999/aps.2017.01277 10. While B, Salvi S, Currie Z, Mudhar HS, Tan JHY (2014) Excision and delayed reconstruction with paraffin section histopathologi cal analysis for periocular sebaceous carcinoma. Ophthal Plast Reconstr Surg 30(2):105–109. https://d oi.o rg/1 0.1 097/IOP.0 0000 00000000013 11. Hamada S, Kersey T, Thaller VT (2005) Eyelid basal cell carci noma: non-Mohs excision, repair, and outcome. Br J Ophthalmol 89(8):992–994. https://doi.org/10.1136/bjo.2004.058834 12. Gill HS, Moscato EE, Seiff SR (2014) Eyelid margin basal cell carcinoma managed with full-thickness en-face frozen sec tion histopathology. Ophthal Plast Reconstr Surg 30(1):15–19. https://doi.org/10.1097/IOP.0b013e3182a74f21 13. McKelvie J, Ferguson R, Ng SGJ (2017) Eyelid reconstruction using the “Hughes” tarsoconjunctival advancement flap: Long term outcomes in 122 consecutive cases over a 13-year period. Orbit 36(4):228–233. https://doi.org/10.1080/01676830.2017. 1310256 14. Stafanous S (2009) Five-year cycle of basal cell carcinoma man agement re-audit. Orbit 28(4):264–269 15. Şahan B, Çiftçi F, Özkan F, Öztürk V (2016) The importance of frozen section-controlled excision in recurrent basal cell carci noma of the eyelids. Turk J Ophthalmol 46(6):277–281. https:// doi.org/10.4274/tjo.48640 16. Leibovitch I, Huilgol SC, Hsuan JD, Selva D (2005) Incidence of host site complications in periocular full thickness skin grafts. Br J Ophthalmol 89(2):219–222. https://d oi.o rg/1 0.1 136/ bjo.2004.052639
complex repairs as opposed to straightforward techniques. Our data are also subject to skew by studies that included a disproportionately higher number of patients than others. Specifically, it is likely that the incidence of skin graft use for periorbital defects in our systematic analysis is greater than the true rate in clinical practice given our inclusion of one study which had many patients whose defects were repaired with skin grafts [16]. Future reviews looking at trends in repair method utilization could consider use of ICD-10 and CPT codes for a more accurate depiction of these rates in clinical practice. One additional limitation of our study is that the authors of the reviewed articles could have differed in their defini tions of which repair techniques qualify as a flap closure. If some authors included linear repairs in their reported total number of cases repaired with a flap, the occurrence of flap reconstruction in this systematic review could be overestimated. The analysis of our results is also limited by the relatively small number of cases that specified the reconstructive tech nique by defect location. Future studies should attempt to categorize the reconstructive technique by defect location if feasible to allow for more clinically relevant analyses. Further, the data in this systematic review did not allow for correlation between reconstructive techniques and the defect size, shape, depth, or patient-specific factors. Reconstruction of periorbital defects is complex and nuanced. The authors’ specialties, tumor expiration method, and reconstructive techniques are varied amongst the lit erature. Future reports should consider the use of standard ized outcome measures and specification of reconstructive technique and complications by defect location and other defect-specific and patient-specific factors to improve the clinical utility of this body of literature. Supplementary Information The online version contains supplemen tary material available at https://d oi.o rg/1 0.1 007/s00403-0 22-0 2523-z. Acknowledgements None. Author contributions LA wrote the abstract and manuscript text. LA prepared all tables and figures. LA, RG, KS, MS, IM, and CB were involved in data collection. All authors reviewed the manuscript. Data availability The dataset analyzed during this study is available from the corresponding author on reasonable request. Declarations Conflict of interest Dr. Ian Maher is an investigator for Pellepharm and Castle and this involves clinical trial participation and research fund ing. Dr. Murad Alam serves as the Editor-in-Chief for the Achieves of Dermatological Research. Authors have no other relevant conflicts of interest.
1 3
Made with FlippingBook Digital Proposal Maker